Resmed Inc. buy Morgan Stanley
Start price
27.10.23
/
50%
€126.35
Target price
27.10.24
€160.06
Performance (%)
89.47%
End price
28.10.24
€239.40
Summary
This prediction ended on 28.10.24 with a price of €239.40. With a performance of 89.47% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.82 are taken into consideration when calculating the performance. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -1.236% | -1.236% | -26.675% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $169.00 price target on the stock, down previously from $180.00.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten